Suspension - Dongjie Intelligent: The controlling shareholder of Zibo Jiangtu, Zibo Zhanheng, plans to transfer 99% of its fund shares, which may lead to a change in the actual controller of the company, resulting in stock suspension [1] Private Placement - Anfu Technology: Plans to raise 1.152 billion yuan to acquire 31% equity in Anfu Energy and raise matching funds [2] Share Buyback - Zhongshun Jierou: Adjusted the share buyback plan with a total fund amount of no less than 160 million yuan [3] External Investment and Daily Operations - Lianhuan Pharmaceutical: The newly built oral solution production line has passed the GMP compliance inspection for the first time [4] - Yiling Pharmaceutical: The new drug registration application for the traditional Chinese medicine Xiaorilianhua Qinggan Granules has been accepted [5] - Jiangte Motor: Yichun Yinli will officially resume production soon [5] - Aisidun: Signed a transaction framework agreement with Xinhongye to transfer 48% equity in Yangzhou Shuguang Optoelectronic Control [5] - Zhuochuang Information: Plans to issue shares overseas (H shares) and apply for listing on the main board of the Hong Kong Stock Exchange [6] - Dajin Heavy Industry: All single pile products for the largest offshore engineering project A phase have been delivered [7] - Hanyu Pharmaceutical: Signed multiple agreements related to the production and supply of Semaglutide injection [7] - Xinghuan Technology: Submitted an application for H share issuance and listing to the Hong Kong Stock Exchange [8] Performance Changes - Xianda Co., Ltd.: Net profit for the first half of the year reached 136 million yuan, a year-on-year increase of 2561.58% [9] - Jinli Permanent Magnet: Net profit for the first half of the year reached 305 million yuan, a year-on-year increase of 154.81% [10] - Shandong Glass Fiber: Net profit for the first half of the year was 8.7277 million yuan, turning from loss to profit [10] - Huace Film & TV: Net profit for the first half of the year reached 118 million yuan, a year-on-year increase of 65.05% [10] - Dazhu CNC: Net profit for the first half of the year reached 600 million yuan, a year-on-year increase of 83.82% [10] - Zhongjing Electronics: Net profit for the first half of the year was 570,000 yuan, turning from loss to profit [10]

北京商报讯(记者丁宁)8月19日晚间，联环药业（600513）发布公告称，公司全资子公司联环药业(安庆) 有限公司(以下简称"联环(安庆)")从安徽省药品监督管理局网站获悉《药品GMP符合性检查告知书》。 公告显示，本次检查为口服溶液1号生产线新建后首次通过药品GMP符合性检查。联环(安庆)本次获得 药品GMP符合性检查结果，表明其相关生产线符合药品GMP要求，标志着联环(安庆)已正式具备符合药 品质量要求的生产能力，为满足相关药品的市场需求奠定了坚实基础。 截至披露日，口服溶液剂生产线投入约为750万元(以上数据未经审计)。 值得一提的是，近期联环药业股价持续大涨，8月19日盘中创下历史新高。截至8月19日收盘，联环药业 报29.47元/股，收涨6.08%。 ...